AnalystsSean Laaman
Sean Laaman's Stock Forecasts

Analyst Ranking
Top 22%
#1127 out of 5254 analysts
Average Return
+20.08%
Win Rate
78%18 out of 23
Risk vs Reward
Poor
Good

Sean Laaman's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Maplight Therapeutics IncMPLT
+114.80%$13.99$30.05
2025-11-21 -
2026-04-17
Strong Buy
Resmed IncRMD
+90.17%$134.65$256.07
2023-10-27 -
2024-10-25
Strong Buy
Beone Medicines LtdONC
+60.28%$206.01$330.19
2024-12-03 -
2025-12-02
Strong Buy
Axsome Therapeutics IncAXSM
+58.91%$105.44$167.55
2025-07-03 -
2026-01-08
Strong Buy
Halozyme Therapeutics IncHALO
+36.28%$58.29$79.44
2025-02-14 -
2026-02-13
Strong Buy

Sean Laaman's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Generate Biomedicines IncGENB
1Strong Buy$20.00+60.64%Initiates Coverage On
a month ago
Eikon Therapeutics IncEIKN
1Strong Buy$32.00+168.91%Initiates Coverage On
2 months ago
Bridgebio Pharma IncBBIO
2Strong Buy$98.00+27.69%Maintains
2 months ago
Exelixis IncEXEL
6Hold$49.00+9.16%Maintains
3 months ago
Axsome Therapeutics IncAXSM
4Hold$204.00+7.94%Downgrades
3 months ago
Certara IncCERT
2Hold$12.00+92.93%Maintains
4 months ago
Bridgebio Oncology Therapeutics IncBBOT
1Strong Buy$20.00+113.90%Initiates Coverage On
5 months ago
Maplight Therapeutics IncMPLT
1Strong Buy$34.00+13.14%Initiates Coverage On
5 months ago
Disc Medicine IncIRON
3Strong Buy$115.00+60.23%Maintains
6 months ago
Resmed IncRMD
2Strong Buy$304.00+33.26%Maintains
6 months ago
Beone Medicines LtdONC
3Strong Buy$383.00+18.26%Maintains
6 months ago
Alector IncALEC
1Strong Sell$1.50N/AAssumes
a year ago
Halozyme Therapeutics IncHALO
1Strong Buy$67.00N/AAssumes
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.